Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer
- Walter van den Bogaert
- , Emmanuel van der Schueren
- , Jean-Claude Horiot
- , Gilles Chaplain
- , Mario Devilhena
- , Silva Raposo
- , Jorge Leonor
- , Simon Schraub
- , Christian Chenal
- , Eric Barthelme
- , Alain Daban
- , Francois Eschwege
- , Dionisio Gonzalez
- , Jan-Willem Leer
- , Han Hamers
- , Vladimir Svoboda
- , Alberto Rigon
- , Giorgio Arcangeli
- , Horst Sack
- , Marleen de Pauw
- Middelheim Hospital
- University Hospital
- Centre Georges-François Leclerc
- Instituto Portuges de Oncologia
- Centre Hospitalier
- Centre Eugène Marquis
- Hopital Notre Dame
- Hopital Jean Bernard
- Institut Gustave Roussy
- Amsterdam UMC - University of Amsterdam
- Leiden University Medical Center
- Verbeeten Instituut
- Solent NHS Trust
- Ospedale Civile
- Istituto Medico e di Ricerca Scientifica
- EORTC Data Center
Research output: Contribution to journal › Article › Academic › peer-review